Eugene Douglass has training in physical and organic chemistry, immunology and computational biology. As an undergraduate (Worcester Polytechnic Institute), he worked with physicists and chemists and published as first and second author in medical‐diagnostics and photovoltaics, respectively. During his doctoral work (Yale University), he designed, synthesized, and tested small‐molecule immunotherapies and fluorescent sensors. Eugene’s postdoctoral work (Columbia University) focused on building and analyzing a new drug-perturbed RNA sequencing (RNAseq) database focused on understanding the mechanism of action of the most common drugs in clinical oncology.